Prognostic implication of intratumoral metabolic heterogeneity in invasive ductal carcinoma of the breast

18F-Fluoromisonidazole PET/CT: A Potential Tool for Predicting Primary Endocrine Therapy Resistance in Breast Cancer

(2013) J. Cheng et al.   JOURNAL OF NUCLEAR MEDICINE

Characterizing the metabolic heterogeneity in human breast cancer xenografts by 3D high resolution fluorescence imaging

(2013) He N Xu et al.   SpringerPlus

Intratumor Heterogeneity Characterized by Textural Features on Baseline 18F-FDG PET Images Predicts Response to Concomitant Radiochemotherapy in Esophageal Cancer

(2011) F. Tixier et al.   JOURNAL OF NUCLEAR MEDICINE

Drug Resistance, Epigenetics, and Tumor Cell Heterogeneity

(2010) T. Hoey   Science Translational Medicine

Evaluation of the role of18FDG-PET/CT in radiotherapy target definition in patients with head and neck cancer

(2008) Katie L. Newbold et al.   ACTA ONCOLOGICA

Stem cell concepts renew cancer research

(2008) J. E. Dick   BLOOD

Intratumoral Metabolic Heterogeneity of Cervical Cancer

(2008) E. A. Kidd et al.   CLINICAL CANCER RESEARCH

Clinicopathological and Prognostic Relevance of Uptake Level using 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging (18F-FDG PET/CT) in Primary Breast Cancer

(2008) S. Ueda et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Phosphorylated ERα, HIF-1α, and MAPK Signaling As Predictors of Primary Endocrine Treatment Response and Resistance in Patients With Breast Cancer

(2008) Daniele Generali et al.   JOURNAL OF CLINICAL ONCOLOGY

Spatial Heterogeneity in Sarcoma 18F-FDG Uptake as a Predictor of Patient Outcome

(2008) J. F. Eary et al.   JOURNAL OF NUCLEAR MEDICINE

Correlation of intra-tumour heterogeneity on 18F-FDG PET with pathologic features in non-small cell lung cancer: A feasibility study

(2008) Angela van Baardwijk et al.   RADIOTHERAPY AND ONCOLOGY